Zu "1211441-98-3" wurden 4 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Ribociclib
Artikelnummer: TGM-T6199-500mg
Description: Ribociclib (LEE011) is an orally available, and highly specific CDK4/6 inhibitor (IC50:10/39 nM). Target: CDK, VEGFR. Smiles: C(N(C)C)(=O)C=1N(C=2C(C1)=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N2)C5CCCC5. References: Li T, et al. Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231...
| Schlagworte: | LEE011 |
| Anwendung: | Antineoplastic, Cyclin-dependent kinase (CDK) inhibitor |
| CAS | 1211441-98-3 |
| MW: | 434.54 D |
ab 36,00 €
LEE011
Artikelnummer: Cay17666-10
LEE011 is a cyclin-dependent kinase (CDK) inhibitor that targets cyclin D1/CDK4 and cyclin D3/CDK6 at nanomolar concentrations. It inhibits retinoblastoma protein phosphorylation, which prevents CDK-mediated G1-S phase transition, arresting the cell cycle in the G1 phase, suppressing DNA synthesis, and inhibiting...
| Schlagworte: | Ribociclib, 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide |
| Anwendung: | Cyclin D1/CDK4 & cyclin D3/CDK6 inhibitor |
| CAS | 1211441-98-3 |
| MW: | 434.5 D |
ab 54,00 €
LEE011
Artikelnummer: SYN-1213-M001
Solid. Soluble in DMSO. Orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathways, with potential antineoplastic activity. Specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation...
| Schlagworte: | LEE-011, Ribociclib |
| Anwendung: | CDK4/CDK6 inhibitor |
| CAS | 1211441-98-3 |
| MW: | 434,5 D |
ab 66,00 €
LEE-011
Artikelnummer: LKT-L1616.5
CDK4/6 inhibitor.
| Schlagworte: | LEE011, Ribociclib |
| Anwendung: | CDK4/6 inhibitor |
| CAS | 1211441-98-3 |
| MW: | 434.54 D |
ab 69,00 €
